Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms

Chiara Barisione1, Silvano Garibaldi1, Claudio Brunelli1

  • 1Division of Cardiology, IRCCS San Martino University Hospital-IST, Research Center of Cardiovascular Biology, University of Genova, Viale Benedetto XV, 6., 16132, Genova, Italy.

Insights

Patients with abdominal aortic aneurysms (AAA) frequently have cardiac damage (CD) and chronic kidney disease (CKD), often undiagnosed. Early identification and treatment of these conditions, along with iron deficiency and anemia, are crucial before surgery.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Surgery

Background:

  • Chronic kidney disease (CKD) and cardiac damage (CD) increase risks in vascular surgery patients.
  • Abdominal aortic aneurysms (AAA) are associated with significant cardiovascular and renal comorbidities.

Purpose of the Study:

  • To determine the prevalence of cardiac damage (CD), chronic kidney disease (CKD), and cardiorenal syndrome (CRS) in patients undergoing AAA repair.
  • To assess the frequency of anemia and iron deficiency (ID) in this patient cohort.

Main Methods:

  • 563 patients with AAA undergoing cardiac screening before endovascular (EVAR) or open surgery (OS) were analyzed.
  • CD was defined by ACC/AHA CHF classification, CKD by CKD-EPI (GFR <60 mL/min/1.73 m²).
  • Anemia and ID were assessed using WHO and CHF criteria.

Main Results:

  • Prevalence of isolated CD was 24.1%, isolated CKD was 15.0%, and combined cardiorenal damage (CRS) was 20.6%.
  • Iron deficiency (ID) prevalence was 23.4%.
  • Anemia frequency increased from 12.8% in no risk factors (NoRF) to 38.8% in CRS patients, with many cases unrecognized.

Conclusions:

  • Unselected AAA patients exhibit high rates of cardiac and kidney damage, alongside high ID/anemia prevalence.
  • Improved identification and management of ID, anemia, CKD, and CD are essential pre-operatively for AAA patients.
  • These findings highlight the need for comprehensive pre-surgical evaluation in AAA patients to mitigate risks associated with cardiorenal comorbidities.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.6K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
520
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
549
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.2K